Methods for measuring tissue impedance and devices thereof
A method and apparatus for measuring an impedance of a tissue region inside a body of a patient. A first guidewire is advanced into a tissue region of a body of a patient, wherein the first guidewire comprises one or more electrodes electrically coupled to the tissue region. A second guidewire is advanced into the body, wherein the second guidewire comprises one or more electrodes electrically coupled to the tissue region of the body of the patient and spaced from the first guidewire. An error correction electrode is electrically coupled to the body. A voltage is applied across the first and the second guidewires. The impedance of the tissue region between the first and the second guidewires is measured while using an electrical pathway created by the error correction electrode.
1. A method for reducing in vivo shunt capacitance while measuring an impedance, the method comprising:
advancing a first guidewire into a tissue region of a body of a patient, wherein the first guidewire comprises one or more electrodes electrically coupled to the tissue region;
advancing a second guidewire into the body, wherein the second guidewire comprises one or more electrodes electrically coupled to the tissue region of the body of the patient and spaced from the first guidewire;
electrically coupling an error correction electrode to the body of the patient, wherein the error correction electrode is structurally independent from the first guidewire and the second guidewire;
applying a voltage across the first and the second guidewires; and
measuring the impedance of the tissue region between the one or more electrodes of the first and the second guidewires while reducing an in vivo shunt capacitance using an electrical pathway created by the structurally independent error correction electrode when a voltage is applied between the first guidewire and the second guidewire.
2. The method as set forth in claim 1 wherein the error correction electrode is located on a third guidewire.
3. The method of claim 2 wherein the providing the error correction electrode in electrical communication with the body further comprises advancing the third guidewire into the body of the patient.
4. The method as set forth in claim 1 wherein the error correction electrode comprises a patch configured to be attached to the body of the patient.
5. The method as set forth in claim 1 wherein the advancing of the first guidewire comprises advancing in an antegrade fashion to a proximal end of a vascular occlusion and advancing of the second guidewire comprises advancing in a retrograde fashion to a distal end of the vascular occlusion.
6. The method as set forth in claim 1 , wherein the shunt capacitance along a first length of the first guidewire and a second length of the second guidewire is reduced.
7. An apparatus for reducing in vivo shunt capacitance while measuring an impedance of a tissue region inside a body of a patient comprising:
an energy source;
a first guidewire and a second guidewire coupled to the energy source, the first and second guidewires configured to be advanced into a tissue region of a body of a patient, the first and second guidewires comprising one or more electrodes configured to be electrically coupled to the tissue region;
an error correction electrode that is structurally independent from the first guidewire and the second guidewire and configured to be in electrical connection with the body of the patient; and
a measurement device configured to measure the impedance of the tissue region between the one or more electrodes of the first and the second guidewires while reducing an in vivo shunt capacitance using an electrical pathway created by the structurally independent error correction electrode when a voltage is applied between the first guidewire and the second guidewire.
8. The apparatus as set forth in claim 7 wherein the error correction electrode is located on a third guidewire.
9. The apparatus as set forth in claim 8 wherein the third guidewire is configured to be advanced into the body of the patient.
10. The apparatus as set forth in claim 7 wherein the error correction electrode comprises a patch configured to be attached to the body of the patient.
11. The apparatus as set forth in claim 7 wherein the first guidewire is configured to be advanced in an antegrade fashion to a proximal end of a vascular occlusion and the second guidewire is configured to be advanced in a retrograde fashion to a distal end of the vascular occlusion.
12. The apparatus as set forth in claim 7 , wherein the measurement device is configured to measure the impedance with a reduced shunt capacitance along a first length of the first guidewire and a second length of the second guidewire.